Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-19 23:17 | 2022-05-17 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $29.15 | 50,000 | $1,457,475 | 232,306 | -17.7% |
| 2022-05-12 23:21 | 2022-05-10 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $27.22 | 25,000 | $680,380 | 232,306 | -9.7% |
| 2022-05-03 23:57 | 2022-05-03 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $28.62 | 25,000 | $715,415 | 232,306 | -9.7% |
| 2021-05-19 23:26 | 2021-05-17 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $22.09 | 50,000 | $1,104,650 | 216,781 | -18.7% |
| 2021-05-14 23:46 | 2021-05-13 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $22.39 | 25,000 | $559,695 | 216,781 | -10.3% |
| 2021-05-07 23:48 | 2021-05-07 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $22.10 | 19,477 | $430,522 | 216,781 | -8.2% |
| 2020-05-14 23:54 | 2020-05-12 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $15.75 | 18,000 | $283,469 | 201,822 | -8.2% |
| 2020-05-07 23:25 | 2020-05-05 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $14.06 | 25,000 | $351,425 | 201,822 | -11.0% |
| 2020-03-26 23:36 | 2020-03-24 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $13.91 | 25,000 | $347,718 | 201,822 | -11.0% |
| 2020-03-19 23:10 | 2020-03-17 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $13.54 | 25,000 | $338,508 | 201,822 | -11.0% |
| 2019-11-16 00:07 | 2019-11-13 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $19.70 | 20,000 | $394,056 | 185,122 | -9.8% |
| 2019-11-09 00:04 | 2019-11-06 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $19.76 | 20,000 | $395,116 | 185,122 | -9.8% |
| 2019-05-24 00:50 | 2019-05-22 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $24.93 | 20,000 | $498,532 | 185,122 | -9.8% |
| 2019-03-15 01:53 | 2019-03-14 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $33.05 | 25,000 | $826,373 | 185,122 | -11.9% |
| 2019-03-08 02:20 | 2019-03-07 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $32.07 | 20,000 | $641,362 | 185,122 | -9.8% |
| 2018-05-25 00:24 | 2018-05-24 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $45.22 | 20,000 | $904,424 | 172,644 | -10.4% |
| 2018-05-18 02:01 | 2018-05-17 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $46.14 | 20,000 | $922,846 | 172,644 | -10.4% |
| 2017-11-04 00:13 | 2017-11-01 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $48.71 | 15,000 | $730,688 | 163,693 | -8.4% |
| 2017-05-20 00:58 | 2017-05-18 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $57.23 | 10,000 | $572,254 | 162,370 | -5.8% |
| 2017-05-12 00:06 | 2017-05-11 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $57.01 | 10,000 | $570,082 | 162,370 | -5.8% |
| 2016-12-01 01:16 | 2016-11-30 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $57.51 | 10,000 | $575,083 | 155,659 | -6.0% |
| 2016-11-18 02:10 | 2016-11-16 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $58.59 | 10,000 | $585,901 | 155,659 | -6.0% |
| 2016-11-11 01:28 | 2016-11-09 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $56.22 | 10,000 | $562,183 | 155,659 | -6.0% |
| 2016-05-19 23:37 | 2016-05-17 | KOPN | KOPIN CORP | LANDINE MICHAEL J | Director | Semiconductors & Related Devices | BUY | $1.78 | 25,000 | $44,450 | 135,000 | +22.7% |
| 2016-04-21 00:19 | 2016-04-20 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $41.09 | 16,875 | $693,402 | 146,762 | -10.3% |
| 2015-12-09 01:35 | 2015-12-07 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $73.02 | 3,750 | $273,830 | 141,324 | -2.6% |
| 2015-12-03 02:12 | 2015-12-01 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $72.18 | 10,000 | $721,768 | 141,324 | -6.6% |
| 2015-09-18 00:05 | 2015-09-17 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $71.20 | 10,000 | $711,951 | 138,680 | -6.7% |
| 2015-09-11 00:05 | 2015-09-10 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $67.61 | 10,000 | $676,052 | 138,680 | -6.7% |
| 2015-05-20 23:58 | 2015-05-18 | KOPN | KOPIN CORP | LANDINE MICHAEL J | Director | Semiconductors & Related Devices | OPT+S | $3.75 | 142 | $533 | 100,000 | -0.1% |
| 2014-12-12 01:41 | 2014-12-09 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $56.82 | 18,000 | $1,022,809 | 130,521 | -12.1% |
| 2014-11-14 01:08 | 2014-11-11 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $52.74 | 15,000 | $791,121 | 130,521 | -10.3% |
| 2014-10-17 00:26 | 2014-10-14 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $40.65 | 15,000 | $609,737 | 130,521 | -10.3% |
| 2014-09-20 00:23 | 2014-09-18 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $45.60 | 15,000 | $684,063 | 130,521 | -10.3% |
| 2014-07-08 00:11 | 2014-07-03 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $51.31 | 7,000 | $359,146 | 130,521 | -5.1% |
| 2013-08-15 00:57 | 2013-08-12 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $33.89 | 1,500 | $50,835 | 118,946 | -1.2% |
| 2013-08-06 00:57 | 2013-08-05 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $34.64 | 13,500 | $467,613 | 118,946 | -10.2% |
| 2013-07-10 00:09 | 2013-07-08 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $28.54 | 20,000 | $570,718 | 118,946 | -14.4% |
| 2013-07-03 00:07 | 2013-07-01 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $29.60 | 20,000 | $592,008 | 118,946 | -14.4% |
| 2013-02-27 01:05 | 2013-02-25 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $20.68 | 5,000 | $103,397 | 110,580 | -4.3% |
| 2013-02-21 01:03 | 2013-02-19 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $21.03 | 10,000 | $210,326 | 110,580 | -8.3% |
| 2013-01-24 01:08 | 2013-01-22 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $22.19 | 10,000 | $221,869 | 110,580 | -8.3% |
| 2013-01-16 01:07 | 2013-01-14 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $21.82 | 10,000 | $218,214 | 110,580 | -8.3% |
| 2012-11-15 01:49 | 2012-11-12 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $20.26 | 6,000 | $121,534 | 107,666 | -5.3% |
| 2012-10-20 00:05 | 2012-10-17 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $20.00 | 1,500 | $30,000 | 107,666 | -1.4% |
| 2012-10-10 00:02 | 2012-10-08 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $20.58 | 20,000 | $411,612 | 107,666 | -15.7% |
| 2012-10-03 23:05 | 2012-10-01 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $20.67 | 20,000 | $413,434 | 107,666 | -15.7% |
| 2012-09-27 00:06 | 2012-09-24 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $20.74 | 20,000 | $414,834 | 107,666 | -15.7% |
| 2012-07-07 00:10 | 2012-07-03 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $18.00 | 20,000 | $360,000 | 107,666 | -15.7% |
| 2012-02-04 01:13 | 2012-02-01 | ALKS | Alkermes plc. | LANDINE MICHAEL J | Officer; SVP, Corp Dev., Alkermes, Inc. | Pharmaceutical Preparations | OPT+S | $18.95 | 12,500 | $236,843 | 101,951 | -10.9% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.